CA
NZ
UK
AU
IND
US
NRX Pharmaceuticals, Inc. Chief Financial Officer Michael S. Abrams filed a Form 4 on November 4, 2026, disclosing the acquisition of 75,000 restricted stock units granted on July 28, 2026.
Director Esi Eggleston Bracey of Williams-Sonoma, Inc. filed a statement of changes in beneficial ownership with the SEC on November 4, 2026, disclosing the acquisition of 107 deferred stock units in the company on November 2, 2026.
Joseph D. Mansueto, Executive Chairman and 10% owner of Morningstar, Inc. (NASDAQ:MORN), filed a Form 4 on November 4, 2026, disclosing sales of common stock across three trading days from November 2 through November 4, 2026, executed under a Rule 10b5-1 trading plan.
Saba Capital Management, L.P. filed a Form 4 on November 4, 2026, disclosing a sale of common stock in PIMCO Dynamic Income Strategy Fund on November 3, 2026.
Director Neal A. Shear of Cheniere Energy, Inc. filed a Form 4 on November 4, 2026, disclosing a disposition of 500 shares of common stock on November 2, 2026, via a gift transaction at a price of $0.
Director Desiree G. Rogers filed a Form 4 with the SEC on November 4, 2026, disclosing the sale of 12,000 shares of Stagwell Inc. Class A Common Stock on November 3, 2026.
Adolfo Fernando Zuberbuhler, Chief Financial Officer of Pampa Energy Inc., filed a Form 4 on November 4, 2026, disclosing a purchase of 3,136 shares of common stock on that same date.
Jonathan Halvorson, Chief Digital & Marketing Officer of Kenvue Inc., filed a Form 4 on November 4, 2026, disclosing the disposition of 89,969 restricted stock units on November 2, 2026, in connection with the closing of Kenvue's acquisition by Kimberly-Clark Corporation.
Director Melanie Healey filed a Form 4 with the SEC on November 4, 2026, reporting the disposition of 151 shares of Kenvue Inc. common stock and 37,794.8 deferred share units on November 2, 2026, in connection with the acquisition of Kenvue by Kimberly-Clark Corporation.
Matthew Orlando, General Counsel of Kenvue Inc. (NYSE:KVUE), filed a Form 4 on November 4, 2026, disclosing the disposition of common stock, stock options, restricted stock units, and performance stock units on November 2, 2026, following Kimberly-Clark Corporation's acquisition of Kenvue.
Please wait processing your request...